Boundless Bio, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BOLD research report →
About the company
Boundless Bio, Inc. , a clinical-stage oncology company, focuses on developing innovative cancer therapies aimed at addressing the significant unmet needs of patients with oncogene amplified tumors. Their core strategy involves targeting extrachromosomal DNA (ecDNA).
- CEO
- Zachary Hornby
- IPO
- 2016
- Employees
- 64
- HQ
- San Diego, CA, US
Price Chart
- Market Cap
- $56.19M
- P/E
- -1.00
- P/S
- 0.00
- P/B
- 0.65
- EV/EBITDA
- -1.59
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -53.60%
- ROIC
- -45.06%
- Revenue
- $0 · 0.00%
- Net Income
- $-58,197,000 · 10.96%
- EPS
- $-2.60 · 32.47%
- Op Income
- $-63,552,000
- FCF YoY
- 25.51%
- 52W High
- $2.79
- 52W Low
- $0.96
- 50D MA
- $1.63
- 200D MA
- $1.32
- Beta
- 0.40
- Avg Volume
- 1.35M
Get TickerSpark's AI analysis on BOLD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 2, 26 | TANG KEVIN | buy | 9,821 |
| Jul 1, 26 | TANG KEVIN | buy | 71,612 |
| Jun 30, 26 | TANG KEVIN | buy | 100 |
| Jun 30, 26 | TANG KEVIN | buy | 25,930 |
| Jun 29, 26 | TANG KEVIN | buy | 777 |
| Jun 29, 26 | TANG KEVIN | buy | 63,985 |
| Jun 26, 26 | TANG KEVIN | buy | 134 |
| Jun 26, 26 | TANG KEVIN | buy | 75,047 |
| Jun 25, 26 | TANG KEVIN | buy | 510 |
| Jun 25, 26 | TANG KEVIN | buy | 145,880 |
Our BOLD coverage
Recent articles, reports, and earnings notes.
No research on BOLD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BOLD report →Similar companies
Peers in the same neighborhood.